Nanopharmaceuticals Market
The global market for nanopharmaceutical drugs is experiencing high demand due to the increasing burden of chronic diseases such as cancer, cardiovascular disease, and immunological diseases. According to WHO (World Health Organization) statistics, the burden of chronic diseases is expected to increase by 57.0% by 2020 compared to 2001. Developing countries are expected to be heavily impacted, accounting for 60.0% of the global burden of chronic diseases. An increase in healthcare expenditure and increased funding for healthcare R&D are driving the growth of the Nanopharmaceuticals Market .
Read More @ https://cmiinfonest.blogspot.com/2022/11/nanopharmaceuticals-market-global.html
